Basic Materials / Specialty ChemicalsNasdaqCM
$1.69
-0.04 (-2.31%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-6.1M · quality 69.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$9M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-66.7%
↓Gross Margin
62.5%
↑Debt/Equity
0.28
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2015–2025 · 10 años de histórico normalizado
Revenue CAGR
+24.9%
FCF CAGR
—
FCF margin
-265.1%
FCF / Net income
0.92x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.2M · net income $-6.4M · FCF $-5.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | $2.2M | $2.2M | $1.9M | $1.2M | $1.0M | $600000.00 | $282000.00 | $143000.00 | $297000.00 | $52000.00 | $318000.00 | $241000.00 |
| Net Income | $-6.4M | $-6.4M | $-6.2M | $-7.7M | $-9.7M | $-8.3M | $-8.4M | $-10.0M | $-11.9M | $-12.3M | $-10.8M | $-18.2M |
| EBITDA | $-6.2M | $-6.2M | $-6.0M | $-7.6M | $-9.5M | $-8.6M | $-7.6M | $-9.9M | $-11.4M | $-11.9M | $-10.3M | $-15.5M |
| EPS | — | — | -8.86 | -115.10 | -1860.00 | -1772.40 | — | — | — | — | — | — |
| Gross Margin | 62.5% | 62.5% | 54.1% | 45.2% | 45.5% | 40.7% | 0.4% | 29.4% | 18.9% | 13.5% | 100.0% | — |
| Operating Margin | -292.9% | -292.9% | -336.5% | -648.1% | -949.4% | -1489.0% | -2813.1% | -7193.7% | -4000.0% | -23684.6% | -3306.9% | -6491.7% |
| Net Margin | -287.4% | -287.4% | -333.0% | -646.3% | -951.4% | -1378.0% | -2969.1% | -7005.6% | -4009.4% | -23626.9% | -3394.7% | -7540.7% |
| Balance Sheet | ||||||||||||
| Debt/Equity | 0.28 | 0.28 | 0.10 | 0.06 | 0.07 | — | 0.17 | 0.05 | 0.04 | 0.08 | 0.01 | -0.04 |
| Current Ratio | 8.90 | 8.90 | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||
| Free Cash Flow | $-5.9M | $-5.9M | $-6.1M | $-7.7M | $-8.8M | $-7.9M | $-7.2M | $-8.1M | $-9.4M | $-10.2M | $-6.8M | $-3.8M |
| Returns | ||||||||||||
| ROE | -66.7% | -66.7% | -246.3% | -121.4% | -183.7% | -82.4% | -215.6% | -390.3% | -188.6% | -163.3% | -99.7% | 160.5% |
| Valuation | ||||||||||||
| P/B | 0.92 | 0.92 | 0.98 | 0.13 | 0.39 | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||
| Revenue Growth | 19.6% | 19.6% | 55.7% | 17.1% | — | 112.8% | 97.2% | -51.9% | 471.2% | -83.6% | 32.0% | — |
| EPS Growth | — | — | 92.3% | 93.8% | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-39.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-8.86 → n/d
Residual
-39.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.